NEWS DETAIL

تحليل لاحق لتجربتي ADMIRAL وCOMMODORE: توقيت الاستجابة للعلاج الأحادي بـ gilteritinib في حالات ابيضاض الدم النخاعي الحاد المتكرر/المقاوم للعلاج مع طفرة FLT3m – aml-hub.com

Post hoc analysis of the ADMIRAL and COMMODORE trials: Timing of response with gilteritinib monotherapy in R/R FLT3m AML aml-hub.com

معلومات طبية July 10, 2026

المحتوى الكامل للمقال

During the 66th ASH Annual Meeting and Exposition, Wang presented findings from a post hoc analysis of the ADMIRAL and COMMODORE trials investigating the timing of response to gilteritinib in patients with R/R FLT3m AML.

المنتجات المرتبطة بهذا المقال

تمت مطابقة هذه المنتجات تلقائيا استنادا الى عنوان المقال وملخصه ومحتواه.

الاسئلة الشائعة

Which products are related to this article?

The system matched these relevant products from the article content: لوسيوس جيلتيريتينيب – اشترِ عبر الإنترنت جيليدكس جيلتيريتينيب 40 ملغ.

How can I view the medicines discussed in this article?

Use the related product cards below the article to review available specifications, prices, product information, and reviews.

Does this article replace advice from a doctor or pharmacist?

No. This content is for general information and health education only. Follow the prescription and individual guidance provided by qualified healthcare professionals.